AZN.L |
ASTRAZENECA PLC |
|
5.80% |
|
|
|
|
|
|
|
|
|
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
79.76B |
5.62% |
|
|
|
|
|
738.00 |
-0.87% |
30.52% |
57.05% |
---|
AMGN |
Amgen Inc. |
158.32B |
5.44% |
|
|
|
|
|
294.53 |
1.60% |
52.57% |
94.34% |
---|
GILD |
Gilead Sciences, Inc. |
112.40B |
4.77% |
|
|
|
|
|
90.19 |
0.48% |
24.72% |
31.19% |
---|
4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.88% |
|
|
|
|
|
|
|
|
|
---|
ILMN |
Illumina, Inc. |
22.23B |
3.84% |
|
|
|
|
|
140.14 |
2.30% |
36.71% |
15.88% |
---|
ARGX |
argenx SE |
36.58B |
3.83% |
|
|
|
|
|
605.92 |
1.54% |
27.35% |
23.72% |
---|
RVMD |
Revolution Medicines, Inc. |
9.55B |
3.75% |
|
|
|
|
|
56.75 |
-0.05% |
85.99% |
54.36% |
---|
INCY |
Incyte Corporation |
13.82B |
3.40% |
|
|
|
|
|
71.72 |
1.89% |
56.44% |
76.87% |
---|
4568.T |
DAIICHI SANKYO CO., LTD. |
|
3.12% |
|
|
|
|
|
|
|
|
|
---|
BPMC |
Blueprint Medicines Corporation |
5.98B |
3.06% |
|
|
|
|
|
94.15 |
-2.56% |
46.30% |
12.86% |
---|
MREO |
Mereo BioPharma Group plc |
575.61M |
2.73% |
|
|
|
|
|
3.72 |
1.09% |
336.40% |
49.73% |
---|
BGNE |
BeiGene, Ltd. |
21.35B |
2.53% |
|
|
|
|
|
190.51 |
-2.08% |
38.65% |
27.95% |
---|
CRSP |
CRISPR Therapeutics AG |
4.09B |
2.39% |
|
|
|
|
|
47.88 |
3.43% |
54.15% |
16.79% |
---|
MRK |
Merck & Co., Inc. |
250.89B |
2.39% |
|
|
|
|
|
99.18 |
-0.68% |
22.82% |
38.87% |
---|
EXEL |
Exelixis, Inc. |
10.17B |
2.34% |
|
|
|
|
|
35.61 |
2.24% |
30.40% |
20.37% |
---|
EXAS |
Exact Sciences Corporation |
9.79B |
2.23% |
|
|
|
|
|
52.91 |
-0.30% |
44.81% |
11.65% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
3.18B |
2.21% |
|
|
|
|
|
55.68 |
0.25% |
56.26% |
38.30% |
---|
NOVN.SW |
NOVARTIS AG |
|
2.20% |
|
|
|
|
|
|
|
|
|
---|
NUVL |
Nuvalent, Inc. |
6.75B |
2.00% |
|
|
|
|
|
94.93 |
2.37% |
41.59% |
23.89% |
---|
GMAB |
Genmab A/S |
13.12B |
1.97% |
|
|
|
|
|
20.65 |
0.88% |
131.86% |
25.31% |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
1.38B |
1.88% |
|
|
|
|
|
13.72 |
2.85% |
67.92% |
14.75% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.46B |
1.68% |
|
|
|
|
|
14.30 |
3.62% |
79.69% |
48.27% |
---|
LNTH |
Lantheus Holdings, Inc. |
6.29B |
1.63% |
|
|
|
|
|
90.52 |
3.66% |
42.57% |
28.92% |
---|
LEGN |
Legend Biotech Corporation |
7.51B |
1.56% |
|
|
|
|
|
40.94 |
2.99% |
63.53% |
45.67% |
---|
CLDX |
Celldex Therapeutics, Inc. |
1.79B |
1.54% |
|
|
|
|
|
27.02 |
3.05% |
60.10% |
34.78% |
---|
GH |
Guardant Health, Inc. |
4.03B |
1.49% |
|
|
|
|
|
32.65 |
5.39% |
54.06% |
19.37% |
---|
JANX |
Janux Therapeutics, Inc. |
2.64B |
1.49% |
|
|
|
|
|
50.31 |
8.19% |
130.14% |
44.35% |
---|
MRUS |
Merus N.V. |
3.11B |
1.42% |
|
|
|
|
|
45.49 |
2.56% |
61.45% |
21.76% |
---|
ACLX |
Arcellx, Inc. |
4.89B |
1.32% |
|
|
|
|
|
90.44 |
3.69% |
59.71% |
42.47% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
2.90B |
1.26% |
|
|
|
|
|
39.02 |
7.49% |
61.47% |
16.77% |
---|
SHL.DE |
SIEMENS HEALTHINEERS AG |
|
1.18% |
|
|
|
|
|
|
|
|
|
---|
COGT |
Cogent Biosciences, Inc. |
1.01B |
1.15% |
|
|
|
|
|
9.13 |
1.67% |
293.37% |
38.01% |
---|
SDGR |
Schrödinger, Inc. |
1.52B |
1.07% |
|
|
|
|
|
20.84 |
2.31% |
70.25% |
50.35% |
---|
MRNA |
Moderna, Inc. |
15.82B |
0.97% |
|
|
|
|
|
41.11 |
7.48% |
81.70% |
86.36% |
---|
BNTX |
BioNTech SE |
27.12B |
0.95% |
|
|
|
|
|
113.13 |
4.53% |
44.51% |
53.51% |
---|
BCYC |
Bicycle Therapeutics plc |
1.42B |
0.90% |
|
|
|
|
|
20.54 |
1.38% |
133.18% |
57.66% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
2.32B |
0.90% |
|
|
|
|
|
26.79 |
0.71% |
81.48% |
25.75% |
---|
NRIX |
Nurix Therapeutics, Inc. |
1.56B |
0.86% |
|
|
|
|
|
22.05 |
-1.43% |
78.20% |
12.02% |
---|
CGEM |
Cullinan Oncology, Inc. |
730.17M |
0.85% |
|
|
|
|
|
12.54 |
2.62% |
91.09% |
42.32% |
---|
RLAY |
Relay Therapeutics, Inc. |
795.07M |
0.73% |
|
|
|
|
|
4.75 |
2.37% |
97.22% |
22.42% |
---|
ORIC |
ORIC Pharmaceuticals, Inc. |
676.74M |
0.72% |
|
|
|
|
|
9.59 |
5.15% |
149.75% |
28.62% |
---|
IMCR |
Immunocore Holdings plc |
1.61B |
0.69% |
|
|
|
|
|
32.28 |
0.50% |
57.55% |
32.60% |
---|
RCUS |
Arcus Biosciences, Inc. |
1.35B |
0.69% |
|
|
|
|
|
14.70 |
2.94% |
96.39% |
20.90% |
---|
TERN |
Terns Pharmaceuticals, Inc. |
491.80M |
0.58% |
|
|
|
|
|
5.79 |
1.40% |
94.20% |
29.92% |
---|
CGON |
CG Oncology, Inc. Common stock |
2.25B |
0.58% |
|
|
|
|
|
33.47 |
3.49% |
79.62% |
22.79% |
---|
JSPR |
Jasper Therapeutics, Inc. |
330.78M |
0.51% |
|
|
|
|
|
22.05 |
0.96% |
93.86% |
25.44% |
---|
ARVN |
Arvinas, Inc. |
1.78B |
0.49% |
|
|
|
|
|
25.86 |
2.99% |
89.66% |
43.56% |
---|
CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
212.78M |
0.49% |
|
|
|
|
|
17.47 |
4.42% |
70.44% |
6.57% |
---|